Sweden has an ambitious target of being fossil-free by 2045. As a part of the initiative, a proposal for decarbonizing aviation in Sweden was announced ten days ago. The proposal suggests that Sweden would introduce a greenhouse gas reduction mandate for aviation fuel sold in Sweden. The reduction level would be 0.8% in 2021, and gradually increase to 27% in 2030. The reduction levels are estimated to be equivalent of 1% (11.000 tons) sustainable aviation fuel in 2021, 5% (56.000 tons) in 2025 and 30% (340 000 tons) in 2030. This makes Sweden an undisputed leader in decarbonizing aviation.
More and more women are protagonists of the bioeconomy. This year, as every year, for the International Women’s Day, we dedicate a tribute to all women who are making the bioeconomy happen all around the world. With their huge competences and their infinite passion, they are the stars of the world bioeconomy. Our best and warmest wishes to all women.
Royal DSM and Cargill established Avansya V.O.F. The 50:50 joint venture is a partnership between the two companies. Both parties announced their intention to establish this joint venture on 8 November 2018 subject to regulatory approvals. Avansya will produce zero-calorie, great-tasting sweeteners through fermentation and will be headquartered at the Biotech Campus Delft (Netherlands).
Nouryon (formerly AkzoNobel Specialty Chemicals) and Gasunie have agreed to supply green hydrogen to BioMCN for the production of renewable methanol from CO2. The companies say it marks the next step in the sustainability of processes in the industry.
Effective 1 April 2019, the joint venture between Royal DSM and Roquette, Reverdia, will be dissolved and the partners will transfer the rights and obligations related to Reverdia’s Biosuccinium® plant in Cassano, Italy to Roquette. Under a non-exclusive license from DSM, Roquette will operate the plant and continue serving customers of Biosuccinium®. Customer service, order processing, and marketing and sales will be integrated into Roquette’s existing business to ensure a smooth transition. DSM, the original developer of the Biosuccinium® technology, will assume the role of exclusive licensor, in line with its business model in this field.
IL BIOECONOMISTA 